跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO ACCORD 75 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO ACCORD 75 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIGATRAN ETEXILATO ACCORD 75 MG CAPSULAS DURAS EFG
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 26, 2023
Approval ID
f37158c1a297c080
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
f37158c1a297c080
Drug Cima Aemps Name
DABIGATRAN ETEXILATO ACCORD 75 MG CAPSULAS DURAS EFG
Register Number
1221665004
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2023-07-26
Dosage Form
CÁPSULA DURA
Dose
75 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
86,47 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 26, 2023
Approval ID
f37158c1a297c080
Type
Standard
Back to CIMA-AEMPS Approvals
